A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23- and 35-gene expression profile tests for use as ancillary diagnostic tools for difficult-to-diagnose melanocytic lesions. J of Skin [Internet]. 2021 Nov. 5 [cited 2026 Apr. 21];5(6):s79. Available from: https://skin.dermsquared.com/skin/article/view/1430